Current
15.9×
5-Year Average
15.7×
All-Time High
30.3×
All-Time Low
7.5×
P/FCF Ratio daily chart for Labcorp Holdings (LH)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/FCF Ratio for Labcorp Holdings (LH) from 2001 to 2025
| 2025 | $20.70B | $1.21B | 17.2× | -0.3× | |
| 2024 | $19.17B | $1.10B | 17.5× | -5.3× | |
| 2023 | $19.30B | $848.10M | 22.8× | +10.6× | |
| 2022 | $17.90B | $1.47B | 12.1× | +2.4× | |
| 2021 | $25.72B | $2.65B | 9.7× | -0.0× | |
| 2020 | $17.05B | $1.75B | 9.7× | -3.8× | |
| 2019 | $14.13B | $1.04B | 13.5× | +1.2× | |
| 2018 | $10.88B | $880.40M | 12.4× | +0.1× | |
| 2017 | $14.00B | $1.14B | 12.2× | -0.6× | |
| 2016 | $11.39B | $886.50M | 12.9× | -2.0× | |
| 2015 | $10.76B | $726.60M | 14.8× | +0.2× | |
| 2014 | $7.84B | $535.50M | 14.6× | +3.7× | |
| 2013 | $6.73B | $616.50M | 10.9× | +0.5× | |
| 2012 | $6.96B | $665.10M | 10.5× | +0.4× | |
| 2011 | $7.17B | $709.90M | 10.1× | +0.1× | |
| 2010 | $7.57B | $757.10M | 10.0× | +0.9× | |
| 2009 | $6.79B | $747.70M | 9.1× | -0.5× | |
| 2008 | $5.95B | $623.40M | 9.6× | -3.4× | |
| 2007 | $7.35B | $566.40M | 13.0× | -2.0× | |
| 2006 | $7.70B | $515.80M | 14.9× | +2.3× | |
| 2005 | $6.06B | $480.60M | 12.6× | -0.7× | |
| 2004 | $5.92B | $443.10M | 13.3× | +4.1× | |
| 2003 | $4.47B | $480.70M | 9.3× | +1.5× | |
| 2002 | $2.89B | $370.60M | 7.8× | -13.5× | |
| 2001 | $4.86B | $227.90M | 21.3× | — |
- 202517.2×
- 202417.5×
- 202322.8×
- 202212.1×
- 20219.7×
- 20209.7×
- 201913.5×
- 201812.4×
- 201712.2×
- 201612.9×
- 201514.8×
- 201414.6×
- 201310.9×
- 201210.5×
- 201110.1×
- 201010.0×
- 20099.1×
- 20089.6×
- 200713.0×
- 200614.9×
- 200512.6×
- 200413.3×
- 20039.3×
- 20027.8×
- 200121.3×
About P/FCF Ratio at Labcorp Holdings (LH)
Labcorp Holdings (LH) P/FCF ratio is 15.9× as of June 5, 2026. The 5-year average is 15.7×. The sector median currently stands at 19.8×. The current ratio is at the 48th percentile of its own 10-year history.
Labcorp Holdings (LH) historical P/FCF ratio has ranged from a low of 7.5× (2022) to a high of 30.3× (2015) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
Labcorp Holdings P/FCF Ratio by Year
Labcorp Holdings P/FCF Ratio 2025: 17.2×
Labcorp Holdings (LH) P/FCF ratio in 2025 was 17.2×, contracted from 17.5× the prior year.
Labcorp Holdings P/FCF Ratio 2024: 17.5×
Labcorp Holdings (LH) P/FCF ratio in 2024 was 17.5×, contracted from 22.8× the prior year.
Labcorp Holdings P/FCF Ratio 2023: 22.8×
Labcorp Holdings (LH) P/FCF ratio in 2023 was 22.8×, expanded from 12.1× the prior year.
Labcorp Holdings P/FCF Ratio 2022: 12.1×
Labcorp Holdings (LH) P/FCF ratio in 2022 was 12.1×, expanded from 9.7× the prior year.
Labcorp Holdings P/FCF Ratio 2021: 9.7×
Labcorp Holdings (LH) P/FCF ratio in 2021 was 9.7×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of Labcorp Holdings (LH), ranked by P/FCF ratio.
| 18.5× | |
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 18.5×
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
Labcorp Holdings (LH) Key Financials
Charts, filings, and peer comparison for every metric